Helen & Robert Appel Alzheimer’s Disease Research Institute

You are here

About Us

Helen and Robert Appel and their philanthropic contributions to the Institute 

Helen and Robert Appel

The Institute owes its existence to the extraordinary generosity of Helen and Bob Appel. The Appels have been generous patrons and loyal friends of Weill Cornell for over a decade. In 2004, Bob Appel was elected to the Board of Overseers and shortly thereafter appointed Campaign Chairman for the Discoveries That Make A Difference Campaign. Bob is currently Vice Chair of the Board of Overseers of Weill Cornell Medical College, and Helen was Chair of the Time Capsule Committee for the new Belfer Research Building that houses the Appel Alzheimer’s Disease Research Institute. 

In 2006, Helen and Bob Appel established the Appel Alzheimer’s Disease Research Institute with a major philanthropic gift. They were inspired to do so by two of their close friends that had been diagnosed with the disease. The Appels understood how critical a research institute focused on Alzheimer’s disease would be for the future of those living with the disease, those who will one day be diagnosed with the disease, and our healthcare system at large. 

This is just one gift, among many, that the Appels have given to Weill Cornell. But donations only tell half the tale. The Appels are as generous with their time and talent as they are with their philanthropic support.  Thanks to them, we have the opportunity to mobilize new resources in the fight against this terrible disease. 

Appel Alzheimer’s Disease Research Institute
No Stone Unturned

Research and therapeutic development carried out by the Appel Institute is not confined to particular disciplines, nor is it constrained by any particular dogma. In the quest to solve what may be the greatest single health challenge of the 21st century, no stone must be left unturned.

This is why both fundamental and applied research is central to the mission of the Institute. Research aimed directly at translating discoveries to cures is essential if Alzheimer’s disease is to be conquered. But in the absence of new discoveries, applied research can only work with what we already know. Breakthroughs come from new knowledge; without that, we are like the drunkard who looks for his keys under the lamppost, even though he dropped them in a dark corner, because the light is better there. Basic research shines a light on the dark corners of our understanding. Translational research finds the keys hidden there.

Weill Cornell Medicine Helen & Robert Appel Alzheimer’s Disease Research Institute 413 East 69th Street New York, NY 10021 Phone: (646) 962-6323 Fax: (646) 962-0579